Nanoparticulate aripiprazole formulations

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/14 (2006.01) A61K 31/496 (2006.01)

Patent

CA 2622758

The present invention is directed to compositions and methods comprising nanoparticulate aripiprazole, or salts or derivatives thereof, having improved bioavailability, faster rates of absorption and a faster onset of therapeutic effect. The nanoparticulate aripiprazole compositions are proposed to have an average effective particle size of less than about 2000 nm, and may be useful for the treatment of diseases and disorders of the central nervous system, including mental diseases and disorders.

La présente invention concerne des procédés et compositions à base d'aripiprazole particulaire, ou de certains de leurs sels ou dérivés, se distinguant par une meilleure biodisponibilité, des vitesses d'absorption plus élevées, et un déclenchement plus rapide de l'effet thérapeutique. Les compositions proposées, qui présentent un calibre particulaire moyen réel inférieur à environ 2000 nm, semblent convenir au traitement d'affections et de troubles du système nerveux central, et notamment les affections et troubles mentaux.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Nanoparticulate aripiprazole formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nanoparticulate aripiprazole formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nanoparticulate aripiprazole formulations will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1506251

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.